Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve

British Journal of Haematology

Volumn 114, Issue 4, 2001, Pages 937-943

  Pratt, G ^a   Rawstron, A C ^a   English, A E ^a   Johnson, R J ^a   Jack, A S ^a   Morgan, G J ^a   Smith, G M ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

CD34+ cells; Haemopoietic engraftment; Peripheral blood stem cell transplant; Stem cell mobilization; Thy 1+ cells

Indexed keywords

BUSULFAN; CARMUSTINE; CD34 ANTIGEN; CD38 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; L SELECTIN; MELPHALAN; THIOTEPA; THY 1 ANTIGEN;

ADULT; ARTICLE; BONE MARROW; BREAST CANCER; CANCER CHEMOTHERAPY; CELL COUNT; CELL MOTILITY; CHRONIC GRANULOCYTIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; HUMAN; LEUKOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NEUTROPHIL; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT;

ADP-RIBOSYL CYCLASE; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; ANTIGENS, THY-1; BONE MARROW CELLS; BREAST NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; L-SELECTIN; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOMA, NON-HODGKIN; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIPLE MYELOMA; NAD+ NUCLEOSIDASE; NEUTROPHILS; PROGNOSIS; STEM CELLS; TRANSPLANTATION IMMUNOLOGY;

EID: 0034786919     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.03027.x     Document Type: Article

References (32)

1. Isolation of a candidate human hematopoietic stem-cell population
2. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation
3. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo
4. Expression of Thy-1 on human hematopoietic progenitor cells
5. Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation
6. Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation
7. Pediatric experience with autologous peripheral blood progenitor cell transplantation: Influence of CD34+ cell dose in engraftment kinetics
8. CD34+/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation
9. The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients
10. Characterization and phenotypic analysis of differentiating CD34+ human bone marrow cells in liquid culture
11. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence
12. Primordial role of CD34+ 38- cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation
13. Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus
14. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation
15. L-selectin expression enhances clonogenesis of CD34+ cord blood progenitors
16. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood
17. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation
18. Hematopoeitic stem cell (HSC) transplantation in Multiple Myeloma with selected autologous peripheral blood CD34+Thy-1+ cells
19. Neutropenia and bacterial infection in acquired immunodeficiency syndrome
20. Rapid hemopoietic engraftment following transplantation of purified CD34+Thy-1+ stem cells in patients with metastatic breast cancer
21. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support
22. CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients
23. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and GCSF
24. Poor engraftment at 3 months predicts for poor survival following autologous peripheral blood stem cell transplantation
25. Mobilisation kinetics of CD34+/Thy-1 dim progenitor cells during recombinant human granulocyte-colony stimulating factor administration in normal donors
26. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery
27. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells
28. The ISHAGE guidelines for CD34+ cell determination by flow cytometry
29. Identification of CD34+ subsets after glycoprotease selection: Engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep
30. Transplantation following high-dose chemo and CD34+Thy1+/Lin- peripheral blood stem cells in patients with Non-Hodgkin's Lymphoma (NHL)
31. Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation
32. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy